The global breast lesion localization methods market size was valued at USD 580.7 Million in 2017 and is projected to expand further at a CAGR of 13.3% during the forecast period. Breast cancer is the most prominent and invasive cancer; thus, increasing prevalence of it among women is expected to drive the market growth.
According to the Breast Cancer Organization, it was estimated that in 2018, 266,120 new cases of invasive and 63,960 cases of non-invasive breast cancer would be diagnosed. Rising number of government and non-government reimbursement policies for breast cancer diagnostics, biopsy, and other related medical procedures is estimated to boost the adoption of breast lesion localization methods.
Rising demand for better healthcare infrastructure and facilities and increasing awareness level about breast cancer screening are also expected to boost the market growth. For instance, national breast cancer screening program in Australia called the Breast Screen Australia, which provides free mammogram test services every two years for women aged between 50 and 74. Developing regions, such as India and China, are also spreading awareness about early diagnosis.
In addition, introduction of technologically advanced products on the grounds of accuracy, safety, and cost-effectiveness is considered as the high impact-rendering factor for the breast lesion localization methods market. Companies, such as Endomagnetics and Cianna Inc. have developed a new range of techniques respectively working on magnetic and electroradar guidance for localization of breast lesions. For instance, SAVI SCOUT localization technology of Cianna Medical, Inc. has performed over 50,000-breast tumor localization in over 375 hospitals across the U.S.
Wire guided localization, also known as needle localization, led the market in 2017 with a revenue share of USD 208.4 Million. This growth was attributed to the early establishment and higher adoption of this technique among end-users. Widely used needle or wire localization devices include RPLN, Duo-System, Q-wire system, and X-Reidy breast lesion localization needles. The radioisotope segment is expected to witness significant growth over the forecast period.
It is one of the latest techniques that are effective, safe, and widely used for preoperative localization of non-palpable, suspicious lesions. Magnetic tracer is expected to witness the fastest growth at a CAGR of 14% over the forecast period owing to the enhanced efficacy through novel mechanisms. It is used to detect early-stage non-palpable cancer. Sienna+ is one of the most popular brands in magnetic tracer used for the detection of the target cancer.
North America is the most matured regional market and accounted for 35.9% of the global industry in 2017. The presence of well-established healthcare infrastructure and key manufacturers in the U.S. is projected to augment the regional growth. Technological advancements coupled with high economic development in this region are also likely to drive the market.
Furthermore, various activities by government and private firms to increase the awareness is expected to boost the region’s development. For instance, Wacoal America, Inc. organized a fund-raising activity, “Fit for the Cure”. The aim was to donate the funds to Susan G. Komen Breast Cancer Foundation and simultaneously spread breast cancer awareness in the U.S.
Asia Pacific is expected to register the fastest CAGR of 15.3% during the forecast period owing to rising disposable income level, high-unmet clinical needs, and increasing patient awareness regarding early diagnosis. In addition, rapidly developing healthcare infrastructure and increasing demand for breast conserving surgery are anticipated to provide potential growth platform for this region. The market is also driven by factors, such as increasing medical tourism in emerging countries of APAC.
Key companies in the market include C.R. Bard, SOMATEX Medical Technologies GmbH, Argon Medical Devices, Inc., Cianna Medical, Inc., Cook Medical, C.P. Medical, and others. These market players are focusing on business expansion in developing regions in an attempt to increase their market share. They have also undertaken several other strategies, such as M&A and product launches.
For instance, in October 2018, Cianna Medical, Inc. signed a merger agreement with Merit Medical Systems, Inc., in which the latter will provide clinical support for research and development to Cianna Medical, Inc. for commercializing new technologies in the market. In addition, in April 2017, C.R Bard with BD announced an agreement under which BD acquired Bard to create differentiated medical technology to improve the process of care and treatment of diseases for healthcare professionals and patients.
Market size value in 2020
USD 834.78 million
Revenue forecast in 2025
USD 1.58 billion
CAGR of 13.3% from 2018 to 2025
Base year for estimation
2014 - 2016
2018 - 2025
Revenue in USD million and CAGR from 2018 to 2025
Revenue forecast, company share, competitive landscape, growth factors and trends
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; U.K.; Germany; Japan; China; India; Brazil; Mexico; South Africa
Key companies profiled
C.R. Bard; SOMATEX Medical Technologies GmbH; Argon Medical Devices, Inc.; Cianna Medical, Inc.; Cook Medical; C.P. Medical
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global breast lesion localization methods market report on the basis of type and region:
Type Outlook (Revenue, USD Million, 2014 - 2025)
Radio Guided Occult-Lesion Localization (ROLL)
Radioactive-Seed Localization (RSL)
Regional Outlook (Revenue, USD Million, 2014 - 2025)
b. The global breast lesion localization methods market size was estimated at USD 739.14 million in 2019 and is expected to reach USD 834.78 million in 2020.
b. The global breast lesion localization methods market is expected to grow at a compound annual growth rate of 13.3% from 2018 to 2025 to reach USD 1.58 billion by 2025.
b. North America dominated the breast lesion localization methods market with a share of 43.8% in 2019. This is attributable to the presence of well-established healthcare infrastructure and key manufacturers in U.S.
b. Some key players operating in the breast lesion localization methods market include C.R. Bard, SOMATEX Medical Technologies GmbH, Argon Medical Devices, Inc., Cianna Medical, Inc., Cook Medical, C.P. Medical, and others.
b. Key factors that are driving the market growth include rising prevalence of breast cancer among women, increasing awareness through cancer screening programs, technology advancements, availability of various techniques, and demand for minimally invasive and accurate procedures.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."